Schedule 13G ownership disclosure

CYCLERION THERAPEUTICS INC

Common Stock, no par value · CUSIP: 23255M204

Event date: 2025-03-31

Filing-level shares
164,777.00
Percent of class
5.1%
  • Tyndall Capital Partners, L.P.

    Shares: 164,777.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-010930
Form type
SCHEDULE 13G/A
Filer
Korsana Biosciences, Inc.
CIK
CIK 1755237
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub